[2.2.2] bicyclic derivatives and methods of use
AssigneeASE Pharmaceuticals, LLC
InventorSusanna A. SAAKIAN
Life of this patent
Estimating the term…
Abstract
Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.
Claims8
A method for reducing the number or strength of seizures in a human subject suffering from epilepsy, the method comprising the step of orally administering to the subject 50-1200 mg of the bicyclo42.2.21-octane-2-carboxylate salt per day at least until the number or strength of seizures in a human subject is reduced.
Dependencies are inferred from the claim text.